Literature DB >> 21920017

Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients.

A W Avolio1, U Cillo, M Salizzoni, L De Carlis, M Colledan, G E Gerunda, V Mazzaferro, G Tisone, R Romagnoli, L Caccamo, M Rossi, A Vitale, A Cucchetti, L Lupo, S Gruttadauria, N Nicolotti, P Burra, A Gasbarrini, S Agnes.   

Abstract

Donor-recipient match is a matter of debate in liver transplantation. D-MELD (donor age × recipient biochemical model for end-stage liver disease [MELD]) and other factors were analyzed on a national Italian database recording 5946 liver transplants. Primary endpoint was to determine factors predictive of 3-year patient survival. D-MELD cutoff predictive of 5-year patient survival <50% (5yrsPS<50%) was investigated. A prognosis calculator was implemented (http://www.D-MELD.com). Differences among D-MELD deciles allowed their regrouping into three D-MELD classes (A < 338, B 338-1628, C >1628). At 3 years, the odds ratio (OR) for death was 2.03 (95% confidence interval [CI], 1.44-2.85) in D-MELD class C versus B. The OR was 0.40 (95% CI, 0.24-0.66) in class A versus class B. Other predictors were hepatitis C virus (HCV; OR = 1.42; 95% CI, 1.11-1.81), hepatitis B virus (HBV; OR = 0.69; 95% CI, 0.51-0.93), retransplant (OR = 1.82; 95% CI, 1.16-2.87) and low-volume center (OR = 1.48; 95% CI, 1.11-1.99). Cox regressions up to 90 months confirmed results. The hazard ratio was 1.97 (95% CI, 1.59-2.43) for D-MELD class C versus class B and 0.42 (95% CI, 0.29-0.60) for D-MELD class A versus class B. Recipient age, HCV, HBV and retransplant were also significant. The 5yrsPS<50% cutoff was identified only in HCV patients (D-MELD ≥ 1750). The innovative approach offered by D-MELD and covariates is helpful in predicting outcome after liver transplantation, especially in HCV recipients. ©Copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 21920017     DOI: 10.1111/j.1600-6143.2011.03732.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  18 in total

Review 1.  Selecting lung transplant candidates: where do current guidelines fall short?

Authors:  Jaime L Hook; David J Lederer
Journal:  Expert Rev Respir Med       Date:  2012-02       Impact factor: 3.772

Review 2.  [Deceased donor liver transplantation].

Authors:  D Seehofer; W Schöning; P Neuhaus
Journal:  Chirurg       Date:  2013-05       Impact factor: 0.955

Review 3.  Recent advances in the surgical treatment of hepatocellular carcinoma.

Authors:  Zenichi Morise; Norihiko Kawabe; Hirokazu Tomishige; Hidetoshi Nagata; Jin Kawase; Satoshi Arakawa; Rie Yoshida; Masashi Isetani
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

4.  The corrected donor age for hepatitis C virus-infected liver transplant recipients.

Authors:  Melisa Dirchwolf; Jennifer L Dodge; Jane Gralla; Kiran M Bambha; Trevor Nydam; Kenneth W Hung; Hugo R Rosen; Sandy Feng; Norah A Terrault; Scott W Biggins
Journal:  Liver Transpl       Date:  2015-08       Impact factor: 5.799

5.  Survival benefit of accepting livers from deceased donors over 70 years old.

Authors:  Christine E Haugen; Mary G Bowring; Courtenay M Holscher; Kyle R Jackson; Jacqueline Garonzik-Wang; Andrew M Cameron; Benjamin Philosophe; Mara McAdams-DeMarco; Dorry L Segev
Journal:  Am J Transplant       Date:  2019-01-25       Impact factor: 8.086

Review 6.  Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.

Authors:  Maurizio Pompili; Giampiero Francica; Francesca Romana Ponziani; Roberto Iezzi; Alfonso Wolfango Avolio
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

7.  Machine-Learning Algorithms Predict Graft Failure After Liver Transplantation.

Authors:  Lawrence Lau; Yamuna Kankanige; Benjamin Rubinstein; Robert Jones; Christopher Christophi; Vijayaragavan Muralidharan; James Bailey
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 8.  Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

Authors:  Alberto Grassi; Giorgio Ballardini
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 9.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

10.  Liver transplantation and hepatitis C.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara
Journal:  Int J Hepatol       Date:  2012-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.